PIK3CA and acute myeloid leukemia: Hyperactivation of the PI3K-AKT signaling axis drives uncontrolled cell proliferation and survival in several types of cancer while its inhibition is considered the most important factor in determining the response to chemotherapy and the outcome of AML [57].